Novartis AG
NVS
$119.14
$0.590.50%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.20% | 0.61% | |||
| Total Other Revenue | 102.07% | -4.44% | |||
| Total Revenue | 8.93% | 0.46% | |||
| Cost of Revenue | 2.95% | -2.72% | |||
| Gross Profit | 10.78% | 1.48% | |||
| SG&A Expenses | 12.56% | -12.68% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -102.70% | 32.14% | |||
| Total Operating Expenses | 6.51% | -7.37% | |||
| Operating Income | 13.34% | 18.77% | |||
| Income Before Tax | 2.81% | 34.16% | |||
| Income Tax Expenses | -36.47% | 71.61% | |||
| Earnings from Continuing Operations | 11.50% | 27.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 666.67% | -50.00% | |||
| Net Income | 12.06% | 27.96% | |||
| EBIT | 13.34% | 18.77% | |||
| EBITDA | 11.01% | 42.04% | |||
| EPS Basic | 13.21% | 29.20% | |||
| Normalized Basic EPS | 14.18% | 14.64% | |||
| EPS Diluted | 13.19% | 28.91% | |||
| Normalized Diluted EPS | 14.11% | 14.98% | |||
| Average Basic Shares Outstanding | -1.02% | -0.96% | |||
| Average Diluted Shares Outstanding | -0.96% | -1.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.58% | -- | |||